Community-based studies revealed a higher prevalence of LV systolic and diastolic dysfunction using the new echocardiographic imaging techniques. Future prospective studies will clarify the ...

Targeting a systolic blood pressure (SBP) below 130 mmHg may significantly reduce hospitalizations in patients with heart failure with preserved ejection fraction (HFpEF), a recent systematic review ...

Aims The epidemiology of the five stages of chronic kidney disease (CKD) in systolic heart failure (HF) patients has predominantly been described in hospitalized White patients, with little known ...

The combined extract of sorghum, adzuki bean, and finger millet (SAFE) can significantly lower both systolic and diastolic blood pressure in spontaneously hypertensive rats, comparable to captopril, a ...

Presentation underscores unique potential for atrioventricular interval modulation ("AVIM”) therapy to manage blood pressure in older, high-risk patients who have indicators of diastolic dysfunction ...

People with certain heart conditions may be more likely to develop low blood pressure (low systolic and low diastolic blood pressure). These can include heart valve problems, heart failure ...

Background Mobility limitation is prevalent in patients with heart failure (HF), but the dose-response relationship between ...

If LVEF is 40% or less a patient is considered to have heart failure with reduced ejection fraction (HFrEF), sometimes known as systolic heart failure, which generally has to be diagnosed in a ...

To determine if you have heart failure, a doctor will take your complete medical history and conduct a physical examination. You may also need some of the following diagnostic procedures: Blood ...

Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the publication of findings from its Phase 2 SEISMiC B study on ...

Researchers will systematically review whether replacing regular sodium salt with alternatives like potassium or magnesium ...

Growth hormone therapy improved exercise capacity, heart function, and quality of life in patients with HFrEF and growth ...